1. Cell Therapeutics, Inc. ( CTIC): Engages in the development, acquisition, and commercialization of drugs for the treatment of cancer. Market cap at $189.6M, most recent closing price at $1.76.

Net institutional purchases in the current quarter at 4.7M shares, which represents about 5.02% of the company's float of 93.65M shares.

Major Holders: FMR, LLC (4.81%); BlackRock Institutional Trust Company, N.A. (2.62%).
 

 

2. Sky-mobi Limited ( MOBI): Engages in the operation of a mobile application store in the People's Republic of China. Market cap at $115.04M, most recent closing price at $3.80.

Net institutional purchases in the current quarter at 537.4K shares, which represents about 5.75% of the company's float of 9.34M shares.

Major Holders: California-Public Employees Retirement System (2.5%); Susquehanna International Group, LLP (.76%).
 

 

3. Navios Maritime Acquisition Corporation ( NNA): Provides marine transportation services. Market cap at $373.49M, most recent closing price at $4.14.

Net institutional purchases in the current quarter at 9.5M shares, which represents about 15.9% of the company's float of 59.75M shares. 

Major Holders: Neuberger Berman Group, LLC (4.44%); Claren Road Asset Management, LLC (3.81%). 
 

 

4. Orion Energy Systems, Inc ( OESX): Engages in the development, manufacture, and sale of lighting and energy management systems, controls, and services. Market cap at $96.97M, most recent closing price at $4.60.

Net institutional purchases in the current quarter at 1.3M shares, which represents about 7.61% of the company's float of 17.09M shares.

Major Holders: Ariel Investments, LLC (16.47%); North Star Investment Management Corp (3.16%).
 

 

5. Saratoga Resources Inc. ( SARA): Engages in the acquisition, exploitation, development, and production of crude oil and natural gas properties in the United States. Market cap at $73.92M, most recent closing price at $2.39.

Net institutional purchases in the current quarter at 1.8M shares, which represents about 10.66% of the company's float of 16.89M shares.

If you liked this article you might like

What Adam Feuerstein Got Right and Wrong About Biotech Stocks in 2016

2016 Was a Terrible Year for Biotech but the Tweets Were on Point

Gilead Sciences' Next Challenge to Incyte's Myelofibrosis Drug Dominance

Insider Trading Alert - LPNT, PATK And CTIC Traded By Insiders

Insider Trading Alert - SPTN, FL And CTIC Traded By Insiders